Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
J Pediatr Pharmacol Ther 19
Research published in Endocrinology demonstrated that both human growth hormone and AOD-9604 significantly increased the expression of beta-3 adrenergic receptors in adipose tissue, restoring suppressed receptor levels in obese animal models to match those in lean controls
4) [37,38,39,40,41,42,43,44,45,46,47,48], as treatment decision depends on the patients condition and the physicians opinion
Full reconstitution guide Advanced calculator Dosing & Reconstitution Guide One combined 12 mg vial educational guide for reconstitution and once-daily total-blend dosing All doses below are stated as total blend (combined AOD-9604 6 mg + CJC-1295 3 mg + Ipamorelin 3 mg)
Prescription Shots vs
Clinical Status: AOD-9604 is a synthetic peptide analog evaluated in multiple human and animal studies for obesity and cartilage repair research
